| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $172.19M | $113.27M | $66.23M | $39.39M | $28.36M |
| R&D | $145.00M | $104.20M | $60.59M | $35.29M | $25.76M |
| SG&A | $27.20M | $9.06M | $5.64M | $4.10M | $2.60M |
| Operating Income | -$172.19M | -$113.27M | -$66.23M | -$39.39M | -$28.36M |
| Interest Expense | $14.40M | $10.30M | $5.33M | $2.11M | $1.26M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$177.04M | -$111.78M | -$63.78M | -$40.37M | -$29.61M |
| EPS (basic) | -3.7900 | -2.8300 | -2.6900 | -2.6400 | -2.2100 |
| EPS (diluted) | -3.7900 | -2.8300 | -2.6900 | -2.6400 | – |
| Shares (diluted) | $46.76M | $39.45M | $23.68M | $15.42M | – |